Signal transducer and activator of transcription 3 (Stat3) regulates host defense and protects mice against herpes simplex virus-1 (HSV-1) infection
- PMID: 27965384
- PMCID: PMC5346178
- DOI: 10.1189/jlb.4A1016-199RR
Signal transducer and activator of transcription 3 (Stat3) regulates host defense and protects mice against herpes simplex virus-1 (HSV-1) infection
Abstract
Signal transducer and activator of transcription 3 (STAT3) mediates cellular responses to multiple cytokines, governs gene expression, and regulates the development and activation of immune cells. STAT3 also modulates reactivation of latent herpes simplex virus-1 (HSV-1) in ganglia. However, it is unclear how STAT3 regulates the innate immune response during the early phase of HSV-1 lytic infection. Many cell types critical for the innate immunity are derived from the myeloid lineage. Therefore, in this study, we used myeloid-specific Stat3 knockout mice to investigate the role of STAT3 in the innate immune response against HSV-1. Our results demonstrate that Stat3 knockout bone marrow-derived macrophages (BMMs) expressed decreased levels of interferon-α (IFN-α) and interferon-stimulated genes (ISGs) upon HSV-1 infection. In vivo, knockout mice were more susceptible to HSV-1, as marked by higher viral loads and more significant weight loss. Splenic expression of IFN-α and ISGs was reduced in the absence of STAT3, indicating that STAT3 is required for optimal type I interferon response to HSV-1. Expression of TNF-α and IL-12, cytokines that have been shown to limit HSV-1 replication and pathogenesis, was also significantly lower in knockout mice. Interestingly, Stat3 knockout mice failed to expand the CD8+ conventional DC (cDC) population upon HSV-1 infection, and this was accompanied by impaired NK and CD8 T cell activation. Collectively, our data demonstrate that myeloid-specific Stat3 deletion causes defects in multiple aspects of the immune system and that STAT3 has a protective role at the early stage of systemic HSV-1 infection.
Keywords: dendritic cells; innate immunity; natural killer cells; type I interferons; viral infection.
© Society for Leukocyte Biology.
Figures
References
-
- Whitley R. J., Roizman B. (2001) Herpes simplex virus infections. Lancet 357, 1513–1518. - PubMed
-
- Zuckerman R. A. (2009) The clinical spectrum of herpes simplex viremia. Clin. Infect. Dis. 49, 1302–1304. - PubMed
-
- Youssef R., Shaker O., Sobeih S., Mashaly H., Mostafa W. Z. (2002) Detection of herpes simplex virus DNA in serum and oral secretions during acute recurrent herpes labialis. J. Dermatol. 29, 404–410. - PubMed
-
- Howie S., Norval M., Maingay J., McBride W. H. (1986) Interactions between herpes simplex virus and murine bone marrow macrophages. Arch. Virol. 87, 229–239. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous
